The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2025 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • What we do
        • Management
        • Sustainability
        • History
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Knowledge Center

Scientific Article Type

  • Article (3)
  • Patent (1)

Authors

  • Boerje Sellergren (3)
  • Emilia Leitao (3)
  • Gyoergy Szekely (3)
  • Jose Luis Santos (3)
  • Marcio Temtem (3)
  • Colin Minchom (2)
  • Frederico Ferreira (2)
  • Antonio Ramos (1)
  • Carlos Alvarez (1)
  • Gyorgy Szekely (1)
  • Joao Bandarra (1)
  • Jose Galindro (1)
  • Marco Gil (1)
  • Peter Villax (1)
  • (-) William Heggie (4)

Publish Date

  • 2011 (3)
  • 2006 (3)
  • 2008 (2)
  • 1999 (2)
  • 1991 (2)
  • 1989 (2)
  • 2018 (1)
  • 2017 (1)
  • 2016 (1)
  • 2013 (1)
  • 2010 (1)
  • 2007 (1)
  • 2001 (1)
  • 2000 (1)
  • 1998 (1)
  • 1997 (1)
  • 1996 (1)
  • 1995 (1)
  • 1994 (1)
  • 1986 (1)
  • (-) 2012 (4)
Patent

Manufacture of a triiodinated contrast agent via a new compound of (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid

Jan 01, 2012 WO 2012175903
Article

Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions

Jan 01, 2012 Separation and Purification Technology (2012), 86, 190-198
Article

Carcinogenic pollutants in drug manufacturing

Jan 01, 2012 Magyar Kemikusok Lapja (2012), 67(2), 34-37
Article

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Jan 01, 2012 Separation and Purification Technology (2012), 86, 79-87
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2025 Hovione
    © 2025 Hovione
    • Privacy Notice
    • Terms and Conditions